WO2000035512A3 - Device and method for delivery of a therapeutic agent to a target tissue in vivo - Google Patents

Device and method for delivery of a therapeutic agent to a target tissue in vivo Download PDF

Info

Publication number
WO2000035512A3
WO2000035512A3 PCT/US1999/025999 US9925999W WO0035512A3 WO 2000035512 A3 WO2000035512 A3 WO 2000035512A3 US 9925999 W US9925999 W US 9925999W WO 0035512 A3 WO0035512 A3 WO 0035512A3
Authority
WO
WIPO (PCT)
Prior art keywords
target tissue
delivery
therapeutic agent
vivo
subject
Prior art date
Application number
PCT/US1999/025999
Other languages
French (fr)
Other versions
WO2000035512A2 (en
WO2000035512A8 (en
Original Assignee
Genotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genotherapeutics Inc filed Critical Genotherapeutics Inc
Priority to AU36910/00A priority Critical patent/AU3691000A/en
Publication of WO2000035512A2 publication Critical patent/WO2000035512A2/en
Publication of WO2000035512A3 publication Critical patent/WO2000035512A3/en
Publication of WO2000035512A8 publication Critical patent/WO2000035512A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/0241—Pointed or sharp biopsy instruments for prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

An apparatus for delivery of a therapeutic agent to a target tissue in vivo is provided which permits delivery of agents such as proteins, nucleic acids, liposomes, lipids, sugars, glycolipids, prodrugs, vectors, or chemotherapeutics for treating cancer, or genetic material for gene therapy directly to a target tissue in vivo, such as a tumor, or an internal organ of a subject. Hence, delivery of the therapeutic agent is independent of the circulatory system of the subject. Furthermore, since the agent is delivered directly to the target tissue, the effect of the therapeutic agent at the target tissue is maximized, and deleterious effects on collateral organs are minimized.
PCT/US1999/025999 1998-11-13 1999-11-15 Device and method for delivery of a therapeutic agent to a target tissue in vivo WO2000035512A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU36910/00A AU3691000A (en) 1998-11-13 1999-11-15 Device and method for delivery of a therapeutic agent to a target tissue (in vivo)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19187398A 1998-11-13 1998-11-13
US09/191,873 1998-11-13

Publications (3)

Publication Number Publication Date
WO2000035512A2 WO2000035512A2 (en) 2000-06-22
WO2000035512A3 true WO2000035512A3 (en) 2000-11-23
WO2000035512A8 WO2000035512A8 (en) 2001-04-12

Family

ID=22707250

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/025999 WO2000035512A2 (en) 1998-11-13 1999-11-15 Device and method for delivery of a therapeutic agent to a target tissue in vivo

Country Status (2)

Country Link
AU (1) AU3691000A (en)
WO (1) WO2000035512A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010068694A1 (en) * 2008-12-09 2010-06-17 Connective Orthopaedics Activation and delivery devices for therapeutic compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808158A (en) * 1985-07-01 1989-02-28 Stockert Instrumente Gmbh Vascular catheter

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808158A (en) * 1985-07-01 1989-02-28 Stockert Instrumente Gmbh Vascular catheter

Also Published As

Publication number Publication date
WO2000035512A2 (en) 2000-06-22
WO2000035512A8 (en) 2001-04-12
AU3691000A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
WO1996034969A3 (en) Gene therapy using replication competent targeted adenoviral vectors
US6856839B2 (en) Use of electromagnetic fields in cancer and other therapies
WO2002019895A3 (en) Apparatus and method for shielding tissue during tumor ablation
US5810888A (en) Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
EP1315840A4 (en) Biopanning and rapid analysis of selective interactive ligands (brasil)
WO1998037907A1 (en) Protection of living systems from the adverse effects of stress
AU577318B2 (en) Microwave hyperthermia
DE69434069D1 (en) Gene therapy for solid tumors, papillomas and warts
AU4479097A (en) A method and an apparatus for treating tumoral diseases (cancer)
WO2001007110A3 (en) Apparatus and method for treating body tissues with electricity or medicaments
WO2004103456A2 (en) Non-invasive apparatus and method for providing rf energy-induced localized hyperthermia
CA2265547A1 (en) Method of treating endothelial injury
DK1033972T3 (en) Drug delivery system with 2-step targeting
IL142194A0 (en) Gene expressed in prostate cancer
ATE226094T1 (en) METHOD FOR DELIVERING MEDICINAL MEDICINAL USING GENE THERAPY
US20070196283A1 (en) Composition for transfection of DNA into the liver
WO2000035512A8 (en) Device and method for delivery of a therapeutic agent to a target tissue in vivo
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
AU2002320348A1 (en) Enhancement of transfection of DNA into the liver
WO2004075977A2 (en) Methods using diffuse field ultrasound-induced hyperthermia
Page et al. Hyperthermia for the treatment of brain tumors
Persson Corresponding author: Bertil RR Persson PhD, MDh. c. prof. fem.
Vaage et al. Inhibition of mouse mammary carcinoma development with doxorubicin in liposomes
Persson Treating tumoural diseases (cancer) with a
RU94028184A (en) Therapy method using light negatively charged ions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
122 Ep: pct application non-entry in european phase